Blog Read the latest perspectives from our team of subject matter experts and others Provider Data Is Now a Boardroom IssueWhen most people think about provider data, they think about provider directories. Health plan executives are thinking about something much bigger. Provider data now influences compliance, reimbursement, member experience,… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Artificial IntelligenceProvider DataProvider Data Is Now a Boardroom IssueWhen most people think about provider data, they think about provider directories. Health plan executives are thinking about something much bigger. Provider data now influences compliance, reimbursement, member experience,… Continue reading → Read the articleyes Artificial IntelligenceDrug DevelopmentThe Next Generation of AI-Powered Clinical DevelopmentI am excited today to share our partnership with Novo Nordisk as our design partner for Study Universe. Just one of many announcements in the near future as the… Continue reading → Read the articleno Provider DataProvider Data Has Become InfrastructureEvery health plan is investing in digital transformation, AI, and better member experiences. Yet all of those initiatives ultimately depend on one thing: confidence in the underlying provider data. At… Continue reading → Read the articleno Artificial IntelligenceProvider DataGhost Networks Are Under Growing ScrutinyFor years, health plans have heavily invested in improving provider directory accuracy through a combination of outreach, audits, and operational processes. But what was once viewed as an ongoing… Continue reading → Read the articleno Artificial IntelligenceProvider DataLeading Health Plans Are Adopting AI to Transform Network OperationsHealth plans are under growing pressure to improve provider directory accuracy, accelerate roster processing, and prepare for a rapidly evolving regulatory environment. Leading organizations are responding by applying AI across… Continue reading → Read the articleno Artificial IntelligenceDrug DevelopmentRethinking Clinical Trials: Why Data, Not Just AI, Will Define the Next EraIn a recent panel discussion on entrepreneurship and operator insights in clinical research, Mitesh Rao, MD, Founder and CEO of OMNY, moderated a candid conversation with four leaders building at… Continue reading → Read the articleno1234›»
